Back    Zoom +    Zoom -
WUXI BIO Tumbles 3%+ as US to Levy 100% Tariff on Branded & Patented Drugs
Recommend
7
Positive
7
Negative
14
From October 1 onwards, the US will impose a 100% tariff on branded or patented drugs except on those from companies with established or under-construction pharmaceutical facilities in the US.

Dragged down by the news, WUXI BIO (02269.HK) opened down 2.95% today (26th) and once bottomed at HKD38.42. It last traded at HKD38.54, down 3.65%, with a volume of 4.9564 million shares, involving HKD192 million.

Related NewsPing An Securities Forecasts HK Stocks' Earnings to Rebound in 2H25, Recommends Focus on AI Tech/ Biopharma/ New Consumption. Premium Defensive Assets
WUXI APPTEC (02359.HK) last printed at HKD106.2, down 4.58%.
AAStocks Financial News